Financials
- Market Capitalization 4.02 B
- Employee 624
- Founded 2009
- CEO Chad Robins
- Website www.adaptivebiotech.com
- Headquarter Washington, United States
- FIGI BBG001J2PFF5
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-41.64
市销率
8.9
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1473 | ELVN Enliven Therapeutics, Inc. - Common Stock | 57.86 USD | -4.36% | -3.20% | +9.09% | +180.06% | 4.24 B USD | ||
| 1493 | RLAY Relay Therapeutics, Inc. - Common Stock | 18.77 USD | -3.35% | -2.04% | +0.48% | +424.30% | 4.11 B USD | ||
| 1517 | TNGX Tango Therapeutics, Inc. - Common Stock | 23.34 USD | -7.67% | -1.10% | -11.46% | +253.10% | 3.94 B USD | ||
| 1533 | IDYA IDEAYA Biosciences, Inc. - Common Stock | 40.11 USD | -3.97% | +1.08% | +12.99% | +23.11% | 3.87 B USD |